Parmax Pharma Ltd

Parmax Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Parmax Pharma Ltd

₹ 45.9 -0.20%
02 May - close price
parmaxpharma.com BSE: 540359
About

Incorporated in 1994, Parmax Pharma Ltd manufactures bulk drugs, drugs intermediates, and specialty chemicals[1]

Key Points

Business Overview:[1]
Company used to do manufacturing bulk drugs and specialty chemicals but it discontinued its business activities for a few years. It deals in active pharmaceutical ingredients and Contract Manufacturing Operations. It plans to extend its activity to the formulation of Tablets, Ointments,
Capsules, and Injectables.

Website BSE
  • Market Cap ₹ 17.2 Cr.
  • Current Price ₹ 45.9
  • High / Low ₹ 54.0 / 25.0
  • Stock P/E
  • Book Value ₹ -0.27
  • Dividend Yield 0.00 %
  • ROCE -58.5 %
  • ROE -195 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -1.67% over past five years.
  • Promoter holding is low: 30.8%
  • Company has a low return on equity of -38.9% over last 3 years.
  • Debtor days have increased from 29.5 to 60.3 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
7.09 1.56 2.13 5.35 6.38 1.40 4.07 1.33 4.26 7.82 9.28 6.28
6.40 2.34 2.26 3.03 5.54 2.05 4.84 2.48 5.06 7.31 9.08 6.17
Operating Profit 0.69 -0.78 -0.13 2.32 0.84 -0.65 -0.77 -1.15 -0.80 0.51 0.20 0.11
OPM % 9.73% -50.00% -6.10% 43.36% 13.17% -46.43% -18.92% -86.47% -18.78% 6.52% 2.16% 1.75%
0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.12 0.01
Interest 0.09 0.09 0.12 0.11 0.05 0.12 0.18 0.16 0.16 0.11 0.13 0.11
Depreciation 0.50 0.46 0.47 0.48 0.47 0.42 0.43 0.45 0.41 0.40 0.40 0.41
Profit before tax 0.12 -1.32 -0.71 1.74 0.33 -1.18 -1.37 -1.75 -1.36 0.01 -0.21 -0.40
Tax % 141.67% 0.00% 0.00% 0.00% 48.48% 0.00% 0.00% 0.00% 7.35% 0.00% 0.00% 0.00%
-0.05 -1.32 -0.70 1.74 0.17 -1.18 -1.37 -1.75 -1.45 0.01 -0.22 -0.39
EPS in Rs -0.13 -3.53 -1.87 4.65 0.45 -3.15 -3.66 -4.68 -3.88 0.03 -0.59 -1.04
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
0.00 0.00 0.00 0.00 0.00 11.89 11.99 20.92 26.17 18.24 15.39 11.02 27.64
0.03 0.02 0.02 0.05 0.05 10.81 10.88 19.15 22.74 15.67 13.14 14.39 27.62
Operating Profit -0.03 -0.02 -0.02 -0.05 -0.05 1.08 1.11 1.77 3.43 2.57 2.25 -3.37 0.02
OPM % 9.08% 9.26% 8.46% 13.11% 14.09% 14.62% -30.58% 0.07%
0.00 0.06 0.06 0.06 0.06 0.05 0.05 0.10 0.09 0.06 0.04 0.05 0.15
Interest 0.00 0.00 0.00 0.00 0.00 0.04 0.03 0.13 0.37 0.39 0.37 0.62 0.51
Depreciation 0.00 0.00 0.00 0.00 0.00 1.09 1.03 1.01 1.94 1.93 1.88 1.71 1.62
Profit before tax -0.03 0.04 0.04 0.01 0.01 0.00 0.10 0.73 1.21 0.31 0.04 -5.65 -1.96
Tax % 0.00% 0.00% 25.00% 200.00% 100.00% 20.00% 41.10% 38.02% 54.84% 375.00% 2.12%
-0.03 0.04 0.02 0.00 -0.01 0.00 0.08 0.43 0.75 0.14 -0.10 -5.78 -2.05
EPS in Rs -0.08 0.10 0.05 0.00 -0.03 0.00 0.21 1.15 2.00 0.37 -0.27 -15.45 -5.48
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: -2%
3 Years: -25%
TTM: 110%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 50%
Stock Price CAGR
10 Years: %
5 Years: 18%
3 Years: 3%
1 Year: 51%
Return on Equity
10 Years: -9%
5 Years: -18%
3 Years: -39%
Last Year: -195%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 3.90 3.90 4.03 4.45 4.45 4.45 4.45 4.45 4.45 4.45 4.45 4.45 4.45
Reserves 0.06 0.09 0.12 0.11 0.10 0.11 0.18 0.61 1.37 1.51 1.40 -4.38 -4.55
0.90 0.92 0.79 0.46 1.02 1.96 5.52 5.26 5.89 5.18 5.37 5.91 5.75
0.08 0.09 0.04 0.06 2.14 10.11 9.56 10.75 11.01 6.83 6.39 9.35 9.51
Total Liabilities 4.94 5.00 4.98 5.08 7.71 16.63 19.71 21.07 22.72 17.97 17.61 15.33 15.16
2.53 2.53 2.53 2.53 2.72 5.86 4.92 9.64 10.84 10.44 9.50 9.27 8.76
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 3.33 0.00 0.00 0.00 0.00 0.10 1.25
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.20 0.20 0.20 0.00 0.00 0.00 0.00
2.41 2.47 2.45 2.55 4.99 10.77 11.26 11.23 11.68 7.53 8.11 5.96 5.15
Total Assets 4.94 5.00 4.98 5.08 7.71 16.63 19.71 21.07 22.72 17.97 17.61 15.33 15.16

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-0.03 -0.01 -0.06 0.00 -0.50 3.88 0.92 2.82 3.53 0.75 0.33 -0.19
0.00 0.00 0.00 0.00 -0.19 -4.23 -3.41 -2.40 -3.15 -1.53 -0.94 -1.59
0.03 0.01 0.00 0.10 0.56 1.14 3.10 -0.23 0.40 -0.91 -0.04 1.43
Net Cash Flow 0.00 0.00 -0.06 0.09 -0.14 0.79 0.61 0.20 0.78 -1.69 -0.65 -0.35

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 60.48 35.01 57.58 23.01 13.61 14.70 60.28
Inventory Days 203.34 278.66 88.17 107.27 154.80 286.55 123.74
Days Payable 609.39 645.07 311.84 269.40 299.82 309.82 382.60
Cash Conversion Cycle -345.57 -331.40 -166.09 -139.12 -131.41 -8.57 -198.58
Working Capital Days -59.86 -71.84 -56.18 -48.26 -36.02 -0.47 -115.59
ROCE % -0.62% 0.82% 0.81% 0.20% 0.19% 0.66% 1.56% 8.40% 14.34% 6.13% 3.67% -58.49%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
30.80% 30.80% 30.80% 30.80% 30.80% 30.80% 30.80% 30.83% 30.80% 30.80% 30.80% 30.80%
69.20% 69.19% 69.19% 69.19% 69.20% 69.19% 69.19% 69.16% 69.19% 69.20% 69.20% 69.20%
No. of Shareholders 1,5901,01,6502,0351,9971,9781,9732,0022,0992,1852,2462,3342,356

Documents

Announcements

Annual reports